Considerations of Protein Subpockets in Fragment-Based Drug Design.

about

Fragment-based drug discovery as alternative strategy to the drug development for neglected diseases.

P2860

Q36382655-31C00FE3-C900-4BBA-8639-A47E64AD4460

P2860

Considerations of Protein Subpockets in Fragment-Based Drug Design.

Item

http://www.wikidata.org/entity/Q42212503

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Considerations of Protein Subpockets in Fragment-Based Drug Design.

@en

Considerations of Protein Subpockets in Fragment-Based Drug Design.

@nl

type

Item

label

Considerations of Protein Subpockets in Fragment-Based Drug Design.

@en

Considerations of Protein Subpockets in Fragment-Based Drug Design.

@nl

prefLabel

Considerations of Protein Subpockets in Fragment-Based Drug Design.

@en

Considerations of Protein Subpockets in Fragment-Based Drug Design.

@nl

P1476

Considerations of Protein Subpockets in Fragment-Based Drug Design.

@en

P2093

Matthew Bartolowits

http://www.w3.org/2001/XMLSchema#string

V Jo Davisson

http://www.w3.org/2001/XMLSchema#string

P2860

The Protein Data Bank

Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists

COFACTOR: an accurate comparative algorithm for structure-based protein function annotation

On the origins of enzyme inhibitor selectivity and promiscuity: a case study of protein kinase binding to staurosporine

Biopython: freely available Python tools for computational molecular biology and bioinformatics

Exploring the role of receptor flexibility in structure-based drug discovery

Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site

The structure of JNK3 in complex with small molecule inhibitors: structural basis for potency and selectivity

Unexpected nanomolar inhibition of carbonic anhydrase by COX-2-selective celecoxib: new pharmacological opportunities due to related binding site recognition

Combined use of computational chemistry, NMR screening, and X-ray crystallography for identification and characterization of fluorophilic protein environments

P304

5-20

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1111/CBDD.12631

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-08-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

281343638

http://www.w3.org/2001/XMLSchema#string

P698

26307335

http://www.w3.org/2001/XMLSchema#string

P921

protein design

P932

5464946

http://www.w3.org/2001/XMLSchema#string

Considerations of Protein Subpockets in Fragment-Based Drug Design.

about

P2860

P2860

Considerations of Protein Subpockets in Fragment-Based Drug Design.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932